The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 14, 2023

Filed:

Jul. 21, 2017
Applicant:

The Hong Kong University of Science and Technology, Hong Kong, CN;

Inventors:

Benzhong Tang, Hong Kong, CN;

Xiujuan Shi, Hong Kong, CN;

Yee Yung Yu, Hong Kong, CN;

Tsz Kin Kwok, Hong Kong, CN;

Zheng Zhao, Hong Kong, CN;

Pengfei Zhang, Hong Kong, CN;

Huifang Su, Hong Kong, CN;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C09K 11/06 (2006.01); C07D 221/14 (2006.01); C07D 213/57 (2006.01); C07D 401/12 (2006.01); C07D 285/14 (2006.01); A61N 5/06 (2006.01); G01N 33/533 (2006.01); G01N 33/58 (2006.01); C07C 211/43 (2006.01);
U.S. Cl.
CPC ...
C09K 11/06 (2013.01); A61N 5/06 (2013.01); G01N 33/533 (2013.01); G01N 33/582 (2013.01); C07C 211/43 (2013.01); C07D 213/57 (2013.01); C07D 221/14 (2013.01); C07D 285/14 (2013.01); C07D 401/12 (2013.01); C09K 2211/1007 (2013.01); C09K 2211/1018 (2013.01);
Abstract

The present subject matter is directed to a luminogen exhibiting aggregation induced emission, wherein T1, T2, and T3 comprise one or more polyynes as a conjugated bridge. The present subject matter is also directed to an AIEgen comprising a hydrophilic pyridium group as a strong electron-withdrawing group; a piperazine group as an electron-donating group; and a α-Cyanostilbene; wherein the AIEgen exhibits aggregation induced emission. The present subject matter is directed to a method of synthesizing an AIEgen and is further directed to a method of labeling comprising incubating a subject having cells with a conjugate formed by conjugating an AIEgen with an antibody; and selectively labeling desired cells by turn-on imaging, wherein labeling occurs when the desired cells are selectively stained by fluorescent emission of the AIEgen upon degradation of the antibody after cellular internalization of the conjugate through endocytosis.


Find Patent Forward Citations

Loading…